Related Experiment Video
Updated: Jul 19, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Remission as the treatment goal--the FIN-RACo trial
T Sokka1, H Mäkinen, K Puolakka
1Jyväskylä Central Hospital, Jyväskylä, Finland. tuulikki.sokka@ksshp.fi
Abstract:
The Finnish Rheumatoid Arthritis Combination Therapy (FIN-RACo) trial is the first rheumatoid arthritis (RA) clinical trial in which remission served as the primary outcome measure. This chapter reviews the philosophical background, study design, and results of the FIN-RACo trial. The study showed that a third of patients with active early RA may achieve remission with a combination of methotrexate (MTX), sulfasalazine (SSZ), hydroxychloroquine (HCQ), and prednisolone.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Racemic Mixtures and the Resolution of Enantiomers
Psychosis: Goals of Pharmacotherapy
